Latest Quarter
2025-12-31
Neuphoria Therapeutics Inc (NEUP)
Revenue
$0.0
Net Income
$1.9M
Operating Margin
N/A
Free Cash Flow
$77.2M
Debt / Assets
33.5%
Values are in USD and rounded to the nearest whole number unless noted.
Swipe horizontally to view all columns.
| Income Statement (Quarterly) | 2025-12-31 | 2025-09-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 0 | 0 | 15,000,000 | 662,715 |
| Cost of Revenue | 248,368 | 250,826 | 165,431 | 0 |
| Gross Profit | -248,369 | -250,826 | 14,835,000 | 662,715 |
| Operating Expenses | ||||
| R&D Expenses | 0 | 0 | 0 | 0 |
| SG&A Expenses | 2,126,918 | 2,573,818 | 1,241,000 | 2,629,187 |
| Operating Expenses | 3,983,226 | 8,301,126 | 2,857,000 | 4,366,226 |
| Operating Income | -4,060,813 | -8,551,953 | 11,977,000 | -3,703,511 |
| Interest Expense | 0 | 0 | 0 | 0 |
| Income Before Tax | 1,829,298 | -15,040,188 | 11,181,000 | -1,931,740 |
| Income Tax Expense | -34,794 | -52,638 | -81,186 | 11,609 |
| Net Income | 1,864,092 | -14,987,549 | 11,262,000 | -1,943,349 |
| Per Share | ||||
| EPS | 0.41 | -6.67 | 0.05 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Statement (Annual) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Revenue | 23,953,671 | 0 |
| Cost of Revenue | 1,014,645 | 0 |
| Gross Profit | 22,939,025 | 0 |
| Operating Expenses | ||
| R&D Expenses | 0 | 0 |
| SG&A Expenses | 10,883,695 | 8,474,591 |
| Operating Expenses | 24,667,256 | 17,892,376 |
| Operating Income | -1,728,231 | -17,892,376 |
| Interest Expense | 0 | 0 |
| Income Before Tax | -1,282,673 | -15,579,486 |
| Income Tax Expense | -716,899 | -87,320 |
| Net Income | -565,773 | -15,492,166 |
| Per Share | ||
| EPS | -0.23 | -0.10 |
| EPS Diluted | 0.00 | 0.00 |
| Balance Sheet (Quarterly) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 21,591,805 | 12,608,000 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 0 | 126,884 |
| Inventory | 0 | 0 |
| Total Current Assets | 22,853,038 | 13,194,000 |
| Property Plant Equipment | 160,118 | 218,969 |
| Goodwill and Intangibles | 20,425,901 | 14,158,000 |
| Total Assets | 43,439,059 | 27,649,000 |
| Liabilities | ||
| Account Payables | 1,753,948 | 2,244,000 |
| Short Term Debt | 226,487 | 155,110 |
| Total Current Liabilities | 6,413,022 | 3,829,000 |
| Long Term Debt | 0 | 117,628 |
| Total Liabilities | 14,566,549 | 10,159,000 |
| Shareholders Equity | ||
| Retained Earnings | -270,979,980 | -177,977,000 |
| Total Shareholders Equity | 28,872,510 | 17,490,000 |
| Balance Sheet (Annual) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Assets | ||
| Cash and Cash Equivalents | 21,591,805 | 12,608,000 |
| Short Term Investments | 0 | 0 |
| Net Receivables | 0 | 126,884 |
| Inventory | 0 | 0 |
| Total Current Assets | 22,853,038 | 13,194,000 |
| Property Plant Equipment | 160,118 | 218,969 |
| Goodwill and Intangibles | 20,425,901 | 14,158,000 |
| Total Assets | 43,439,059 | 27,649,000 |
| Liabilities | ||
| Account Payables | 1,753,948 | 2,244,000 |
| Short Term Debt | 226,487 | 155,110 |
| Total Current Liabilities | 6,413,022 | 3,829,000 |
| Long Term Debt | 0 | 117,628 |
| Total Liabilities | 14,566,549 | 10,159,000 |
| Shareholders Equity | ||
| Retained Earnings | -270,979,980 | -177,977,000 |
| Total Shareholders Equity | 28,872,510 | 17,490,000 |
| Cash Flow Statement (Quarterly) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Operating Activities | ||
| Net Income | -369,632,000 | -15,492,000 |
| Depreciation & Amortization | 662,890,000 | 662,991 |
| Stock Based Compensation | 163,772,000 | 814,808 |
| Change in Working Capital | -496,826 | 1,455,000 |
| Operating Cash Flow | 77,229,000 | -14,681,000 |
| Investing Activities | ||
| Capital Expenditure | 0 | 0 |
| Investments | 0 | 0 |
| Investing Cash Flow | 0 | 0 |
| Financing Activities | ||
| Debt Repayment | 0 | 0 |
| Common Stock Issued/Repurchased | 1,528,276 | 10,112,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 1,528,276,000 | 15,109,000 |
| Summary | ||
| Free Cash Flow | 77,229,000 | -14,681,000 |
| Net Change in Cash | 1,601,755,000 | 504,991 |
| Cash Flow Statement (Annual) | 2025-06-30 | 2024-06-30 |
|---|---|---|
| Operating Activities | ||
| Net Income | -369,632,000 | -15,492,000 |
| Depreciation & Amortization | 662,890,000 | 662,991 |
| Stock Based Compensation | 163,772,000 | 814,808 |
| Change in Working Capital | -496,826 | 1,455,000 |
| Operating Cash Flow | 77,229,000 | -14,681,000 |
| Investing Activities | ||
| Capital Expenditure | 0 | 0 |
| Investments | 0 | 0 |
| Investing Cash Flow | 0 | 0 |
| Financing Activities | ||
| Debt Repayment | 0 | 0 |
| Common Stock Issued/Repurchased | 1,528,276 | 10,112,000 |
| Dividends Paid | 0 | 0 |
| Financing Cash Flow | 1,528,276,000 | 15,109,000 |
| Summary | ||
| Free Cash Flow | 77,229,000 | -14,681,000 |
| Net Change in Cash | 1,601,755,000 | 504,991 |